- Home
- PCVX vs AZZ Comparison
PCVX vs AZZ Comparison
Compare PCVX & AZZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCVX
- AZZ
- Stock Information
- Founded
- PCVX 2013
- AZZ 1956
- Country
- PCVX United States
- AZZ United States
- Employees
- PCVX N/A
- AZZ N/A
- Industry
- PCVX Biotechnology: Pharmaceutical Preparations
- AZZ Industrial Specialties
- Sector
- PCVX Health Care
- AZZ Industrials
- Exchange
- PCVX Nasdaq
- AZZ Nasdaq
- Market Cap
- PCVX 4.0B
- AZZ 3.3B
- IPO Year
- PCVX 2020
- AZZ N/A
- Fundamental
- Price
- PCVX $33.02
- AZZ $117.02
- Analyst Decision
- PCVX Strong Buy
- AZZ Buy
- Analyst Count
- PCVX 8
- AZZ 6
- Target Price
- PCVX $135.00
- AZZ $109.67
- AVG Volume (30 Days)
- PCVX 1.5M
- AZZ 229.1K
- Earning Date
- PCVX 11-04-2025
- AZZ 10-08-2025
- Dividend Yield
- PCVX N/A
- AZZ 0.58%
- EPS Growth
- PCVX N/A
- AZZ 908.98
- EPS
- PCVX N/A
- AZZ 8.62
- Revenue
- PCVX N/A
- AZZ $1,586,498,000.00
- Revenue This Year
- PCVX N/A
- AZZ $6.99
- Revenue Next Year
- PCVX N/A
- AZZ $4.09
- P/E Ratio
- PCVX N/A
- AZZ $13.57
- Revenue Growth
- PCVX N/A
- AZZ 1.70
- 52 Week Low
- PCVX $27.66
- AZZ $70.90
- 52 Week High
- PCVX $121.06
- AZZ $118.72
- Technical
- Relative Strength Index (RSI)
- PCVX 55.75
- AZZ 62.80
- Support Level
- PCVX $30.89
- AZZ $110.50
- Resistance Level
- PCVX $32.32
- AZZ $117.00
- Average True Range (ATR)
- PCVX 1.19
- AZZ 2.43
- MACD
- PCVX 0.30
- AZZ -0.17
- Stochastic Oscillator
- PCVX 84.68
- AZZ 84.68
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.
About AZZ AZZ Inc.
AZZ Inc is a provider of galvanizing and a variety of metal coating solutions and coil coating solutions to a broad range of end markets in North America. The company's operating segment consists of Metal Coatings, Precoat Metals, and Infrastructure Solutions. The company generates the majority of its revenue from the Precoat Metals segment, which provides coil coating application of protective and decorative coatings and related value-added downstream processing for steel and aluminum coils. Geographically, the company generates the majority of its revenue from the United States.